...Point Sinks on ASCO Update" ). CPP to pursue approval of FAP combo despite miss Cancer Prevention Pharmaceuticals Inc....
...CPP-1X/sul, CPP-1X/sulindac) repotrectinib (TPX-0005) Tecentriq (Brand), RG7446 (Compound #), MPDL3280A (Compound #), atezolizumab (Generic), Tecentriq (Other), Anti-PDL1 (Other) Cancer Prevention Pharmaceuticals Inc. Exelixis...

.../ Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) Zydis rimegepant Treat acute migraine Submit NDA 2Q19 Cancer Prevention Pharmaceuticals Inc....

...Phase III trial to treat familial adenomatous polyposis (FAP). The candidate is being developed with Cancer Prevention Pharmaceuticals Inc....

...Phase III trial to treat familial adenomatous polyposis (FAP). The candidate is being developed with Cancer Prevention Pharmaceuticals Inc....

...eflornithine (difluoromethylornithine, DFMO), a selective inhibitor of ornithine decarboxylase (ODC), and sulindac, a generic NSAID. Cancer Prevention Pharmaceuticals Inc....
...damage at 18 months, gastritis histopathology score and safety Status: Phase II started Milestone: NA Alicia Parker CPP-1X Cancer Prevention Pharmaceuticals Inc....

...exclusively develop and commercialize the product in North America (see BioCentury, Feb. 1, 2016 ). Cancer Prevention Pharmaceuticals Inc....
...an ODC polymorphism and excretion of 4 urinary polyamines Status: Phase III ongoing Milestone: NA Meghan Sullivan CPP-1X/sulindac DFMO/sulindac eflornithine/sulindac Cancer Prevention Pharmaceuticals Inc. Sucampo...

...drug Amitiza lubiprostone, and an option to a combination of CPP-1X (eflornithine) and sulindac from Cancer Prevention Pharmaceuticals Inc....

...conditions. Last December, it filed to raise up to $28.8 million. Cancer Prevention Pharmaceuticals Inc. , Tucson, Ariz. Alex Himes Cancer Prevention Pharmaceuticals Inc....

...C) 3/9/16 TBD Mkt (tools & services) Visterra Inc. 1/5/16 Up to $69M Ph II Cancer Prevention Pharmaceuticals Inc....

...S.A. and Cipher Pharmaceuticals Inc. market Vaniqa eflornithine to treat unwanted facial hair in women. Cancer Prevention Pharmaceuticals Inc....